AKT1 and melanoma: Mechanistic studies focused on integrin signaling, PI3K/AKT/mTOR activation, and metabolic reprogramming.<h4>Results</h4>SAM.1 significantly enhanced the cytotoxic activity of Vγ9Vδ2 T cells against A375 melanoma cells <i>in vitro</i>.